Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Arterial hypertension in cancer: The elephant in the room
Giacomo Tini, Matteo Sarocchi, Giuliano Tocci, et al.
International Journal of Cardiology (2019) Vol. 281, pp. 133-139
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

The Relationship between Association between Blood Pressure and Risk of Cancer Development
Nikolaos Tzenios, Mary Tazanios, Mohamad Chahine
(2022)
Open Access | Times Cited: 162
The immuno-oncological challenge of COVID-19
Lisa Derosa, Cléa Melenotte, Frank Griscelli, et al.
Nature Cancer (2020) Vol. 1, Iss. 10, pp. 946-964
Open Access | Times Cited: 117
Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
Daan C.H. van Dorst, Stephen J.H. Dobbin, Karla B Neves, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 1040-1061
Open Access | Times Cited: 96
Diretriz Brasileira de Cardio-oncologia – 2020
Ludhmila Abrahão Hajjar, Isabela Bispo Santos da Silva Costa, Marcelo Antônio Cartaxo Queiroga Lopes, et al.
Arquivos Brasileiros de Cardiologia (2020) Vol. 115, Iss. 5, pp. 1006-1043
Open Access | Times Cited: 72
Etiology and management of hypertension in patients with cancer
Turab Mohammed, Meghana Singh, John Glenn Tiu, et al.
Cardio-Oncology (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 60
Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer
Yinghui Wang, Yonggang Wang, Xiaorong Han, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 48
Screening for Coronary Artery Disease in Cancer Survivors
R. Velusamy, Mark Nolan, Andrew Murphy, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 1, pp. 22-38
Open Access | Times Cited: 39
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 9
The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis
Zofia Wicik, Pamela Czajka, Ceren Eyileten, et al.
Platelets (2022) Vol. 33, Iss. 7, pp. 1052-1064
Closed Access | Times Cited: 29
Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis
Morgan Connaughton, Mahsa Dabagh
Healthcare (2022) Vol. 10, Iss. 6, pp. 1074-1074
Open Access | Times Cited: 29
A contemporary update on cancer and takotsubo syndrome
Giacomo Tini, Luca Arcari, Raffaella Mistrulli, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 5
Cardio-Oncology and Heart Failure: A Scientific Statement from the Heart Failure Society of America
Michelle Bloom, Jacqueline B. Vo, Jo E. Rodgers, et al.
Journal of Cardiac Failure (2024)
Closed Access | Times Cited: 4
Preexisting hypertension and cancer therapy: evidence, pathophysiology, and management recommendation
Lida Koskina, Ioannis Andrikou, Costas Thomopoulos, et al.
Journal of Human Hypertension (2023) Vol. 37, Iss. 5, pp. 331-337
Closed Access | Times Cited: 10
Metabolic dysfunction‐associated steatotic liver disease and cancer risk: A cohort study
Peng Yu, Peng Wang, Fubin Liu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Cancer screening and its associated factors in hypertensive individuals: new insights from the 2021 STEPs national study in Iran
Dorsa Salabat, Sheida Sarrafzadeh, Ozra Tabatabaei-Malazy, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Unsupervised discovery of clinical disease signatures using probabilistic independence
Thomas A. Lasko, William W. Stead, John M. Still, et al.
Journal of Biomedical Informatics (2025), pp. 104837-104837
Open Access
Hypertensive Cardiotoxicity in Cancer Treatment—Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies—Epidemiology, Incidence, and Pathophysiology
Robin Chung, Sara Tyebally, Daniel Chen, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3346-3346
Open Access | Times Cited: 27
New tricks of old drugs: Repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies
Mei Zhang, Xianfeng Chen, Norbert Radacsi
Journal of Controlled Release (2020) Vol. 329, pp. 96-120
Open Access | Times Cited: 27
Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
Valentina Mercurio, Alessandra Cuomo, Christian Cadeddu Dessalvi, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 641-641
Open Access | Times Cited: 26
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies
Giacomo Tini, Giuliano Tocci, Allegra Battistoni, et al.
Current Heart Failure Reports (2023) Vol. 20, Iss. 1, pp. 56-62
Open Access | Times Cited: 9
Antihypertensive Medication Adherence and Cardiovascular Outcomes in Patients With Cancer: A Nationwide Population‐Based Cohort Study
Mi‐Hyang Jung, So‐Young Lee, Jong‐Chan Youn, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 14
Open Access | Times Cited: 9
Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
Jun-Jie Yu, Fangang Meng, Wenxia Sui, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice
Giacomo Tini, Alessandra Cuomo, Allegra Battistoni, et al.
International Journal of Cardiology (2021) Vol. 349, pp. 134-137
Closed Access | Times Cited: 18
Antihypertensive Drugs and Risk of Cancer: Between Scylla and Charybdis
Elias Sanidas, Maria Velliou, Dimitrios Papadopoulos, et al.
American Journal of Hypertension (2020) Vol. 33, Iss. 12, pp. 1049-1058
Open Access | Times Cited: 18
Validation of the comprehensive score for financial toxicity for Brazilian culture
Luciana de Alcântara Nogueira, Francisco José Koller, Larissa Marcondes, et al.
ecancermedicalscience (2020) Vol. 14
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top